Strong Revenue RecoveryThe company delivered a dramatic revenue rebound (224.12% yoy in the latest year), signaling renewed product demand or market re-entry. Sustained top-line expansion over several quarters can fund scale, support margin improvement, and demonstrate commercial traction in its software application market.

Improving Free Cash FlowFree cash flow growth improving suggests the business is starting to convert sales into discretionary cash. If maintained, this trend reduces reliance on external financing, enables reinvestment in product development or sales, and supports a path to sustainable operations beyond short-term liquidity fixes.

Lean Operating FootprintA small employee base indicates a lean cost structure typical of scalable software businesses. Lower fixed payroll overhead can accelerate operating leverage as revenue grows, enabling quicker margin expansion provided the company maintains product delivery and controls customer acquisition costs.

Bears Say

Negative Shareholders' EquityNegative equity indicates the company has liabilities exceeding assets, a structural solvency concern. Over the medium term this constrains access to capital, raises creditor risk aversion, and may force asset sales or dilutive financing, undermining strategic options and long-term stability.

High LeverageSignificant leverage increases refinancing and interest-rate risk, limiting financial flexibility. With elevated debt burdens, the company may struggle to fund growth investments or absorb revenue volatility, increasing the probability of covenant breaches or distress during adverse industry cycles.

Negative Operating Cash FlowNegative operating cash flow denotes that core operations are not yet self-funding, requiring recurring external financing. Persisting operational cash deficits can deplete liquidity, impede reinvestment in product and sales, and exacerbate solvency issues given the company’s existing negative equity and high leverage.

8156 FAQ

What was Sinopharm Tech Holdings Limited’s price range in the past 12 months?

Sinopharm Tech Holdings Limited lowest stock price was HK$0.09 and its highest was HK$0.44 in the past 12 months.

What is Sinopharm Tech Holdings Limited’s market cap?

Sinopharm Tech Holdings Limited’s market cap is HK$196.44M.

When is Sinopharm Tech Holdings Limited’s upcoming earnings report date?

Sinopharm Tech Holdings Limited’s upcoming earnings report date is Sep 25, 2026 which is in 191 days.

How were Sinopharm Tech Holdings Limited’s earnings last quarter?

Sinopharm Tech Holdings Limited released its earnings results on Feb 26, 2026. The company reported -HK$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.006.

Is Sinopharm Tech Holdings Limited overvalued?

According to Wall Street analysts Sinopharm Tech Holdings Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Sinopharm Tech Holdings Limited pay dividends?

Sinopharm Tech Holdings Limited does not currently pay dividends.

What is Sinopharm Tech Holdings Limited’s EPS estimate?

Sinopharm Tech Holdings Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Sinopharm Tech Holdings Limited have?

Sinopharm Tech Holdings Limited has 633,693,050 shares outstanding.

What happened to Sinopharm Tech Holdings Limited’s price movement after its last earnings report?

Sinopharm Tech Holdings Limited reported an EPS of -HK$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.273%.

Which hedge fund is a major shareholder of Sinopharm Tech Holdings Limited?

Currently, no hedge funds are holding shares in HK:8156

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Sinopharm Tech Holdings Limited

Sinopharm Tech Holdings Limited, an investment holding company, engages in lottery business in the People's Republic of China and Hong Kong. The company operates through Provision of Lottery-Related Services, Provision of Internet Plus Services, Manufacturing and Distribution of Personal Protective Equipment, and Other Services segments. It offers lottery-related hardware and software systems. The company is also involved in the provision of Internet plus solution services to health care, government affairs, leasing, public security, and other industries; and supply chain management, data analysis, and related services, as well as trading of goods through internet platform. In addition, it offers corporate management services; and distribution of personal protective equipment. The company was formerly known as China Vanguard You Champion Holdings Limited and changed its name to Sinopharm Tech Holdings Limited in June 2019. Sinopharm Tech Holdings Limited was founded in 1999 and is headquartered in Sha Tin, Hong Kong.